Vireo Health acquires Hawthorne Gardening

Vireo Growth has finalized the acquisition of The Hawthorne Gardening Company for $113 million, a move aimed at bolstering its supply chain management and operational efficiencies in the agriculture sector. The transaction, which involves the issuance of subordinate voting shares and warrants, is expected to enhance Vireo's competitive edge by integrating Hawthorne's assets, including cash, working capital, and inventory contributions.

The acquisition agreement entailed Vireo issuing 213 million subordinate voting shares to Good Dog Holdings and granting a warrant to purchase 80 million shares at an exercise price of $0.85 per share over a period of five years. Vireo has gained $35 million in cash, $58 million in net working capital, and $20 million worth of inventory to be supplied across two years. Industry executive Chris Hagedorn, from Scotts Miracle-Gro, will be nominated to Vireo's Board, reflecting deepening ties between the two companies.

John Mazarakis, CEO of Vireo Growth, emphasized that the acquisition will significantly strengthen Vireo's balance sheet through the infusion of approximately $110 million in cash and working capital. This deal is expected to optimize Vireo's procurement platform, facilitating better supply chain management and driving cost efficiency across its portfolio. Both Mazarakis and Hagedorn underscored the strategic alignment of Hawthorne with Vireo's existing operations.

Within the competitive landscape of the agriculture sector, Vireo's acquisition enhances its capabilities amidst rising importance on efficient resource management and operational scalability. The transaction reflects a broader industry trend towards consolidation and vertical integration as companies seek to gain leverage through expanded operational and supply chain capacities.

Looking ahead, the execution of warrants and integration of inventory supply will mark key milestones in the transaction’s successful completion. Vireo will also prepare for the election of Hagedorn to its Board at the upcoming shareholder meeting in 2026, which may signal further collaborative opportunities between Vireo and Scotts Miracle-Gro, to optimize the potential of the Hawthorne business.